TSC2 mutation analysis as a biomarker for lymphangioleiomyomatosis (LAM)
Awardee: David Kwiatkowski
Institution: Brigham and Women's Hospital
Award Amount: $50,500
Funding Period: January 1, 2016 - December 31, 2016
Previous
Previous
Characterization of NPC1-I1061T proteostasis machinery for development of NPC therapeutics
Next
Next